As of January 22, 2025, UroGen Pharma (URGN) has a market cap of $0.42 billion USD. According to our data, UroGen Pharma is ranked No.6315 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.42 B |
-5.63%
|
Dec 31, 2024 | $0.45 B |
-29.00%
|
Dec 29, 2023 | $0.63 B |
69.11%
|
Dec 30, 2022 | $0.37 B |
-6.73%
|
Dec 31, 2021 | $0.40 B |
-47.23%
|
Dec 31, 2020 | $0.76 B |
-46.00%
|
Dec 31, 2019 | $1.41 B |
-22.50%
|
Dec 31, 2018 | $1.82 B |
15.72%
|
Dec 29, 2017 | $1.57 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Karyopharm Therapeutics
KPTI
|
$84.09 M |
0.000 M
|
USA
|
Syndax Pharmaceuticals
SNDX
|
$1.20 B |
0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Market Cap | = | URGN Stock Price | * | URGN Shares Outstanding |
= | $10.05 | * | 42.20 M | |
= | $0.42 B |